XML 40 R31.htm IDEA: XBRL DOCUMENT v3.25.3
Net Income (Loss) Per Share (Tables)
9 Months Ended
Sep. 30, 2025
Earnings Per Share [Abstract]  
Schedule of Computation of Basic and Diluted Net Income (Loss) per Share

The following table sets forth the computation of basic and diluted net income (loss) per share (in thousands, except for per share data):

 

 

Three Months Ended September 30,

 

 

Nine Months Ended September 30,

 

 

 

2025

 

 

2024

 

 

2025

 

 

2024

 

Amounts used for basic and diluted per share calculations:

 

 

 

 

 

 

 

 

 

 

 

 

Net income (loss) attributable to Agenus Inc. common stockholders

 

$

63,860

 

 

$

(66,440

)

 

$

10,531

 

 

$

(181,514

)

 

 

 

 

 

 

 

 

 

 

 

 

 

Weighted average number of Agenus Inc. common shares outstanding - basic

 

 

31,886

 

 

 

21,550

 

 

 

28,184

 

 

 

20,995

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Effect of potentially dilutive securities:

 

 

 

 

 

 

 

 

 

 

 

 

    Share based compensation awards

 

 

914

 

 

 

 

 

 

22

 

 

 

 

    Warrants

 

 

58

 

 

 

 

 

 

58

 

 

 

 

Weighted average number of Agenus Inc. common shares outstanding - diluted

 

 

32,858

 

 

 

21,550

 

 

 

28,264

 

 

 

20,995

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Net income (loss) attributable to Agenus Inc. per common share:

 

 

 

 

 

 

 

 

 

 

 

 

    Basic

 

$

2.00

 

 

$

(3.08

)

 

$

0.37

 

 

$

(8.65

)

    Diluted

 

$

1.94

 

 

$

(3.08

)

 

$

0.37

 

 

$

(8.65

)

Schedule of Anti-dilutive Securities Excluded from Computation of Diluted Weighted Average Shares Outstanding The following securities (listed on an as-if-converted-to-Common-Stock basis) have been excluded from the computation of diluted weighted average shares outstanding as of September 30, 2025 and 2024, as they would be anti-dilutive (in thousands):

 

 

 

Three Months Ended September 30,

 

 

Nine Months Ended September 30,

 

 

 

2025

 

 

2024

 

 

2025

 

 

2024

 

Warrants

 

 

974

 

 

 

965

 

 

 

974

 

 

 

965

 

Stock options

 

 

4,429

 

 

 

3,313

 

 

 

5,125

 

 

 

3,313

 

Non-vested shares

 

 

74

 

 

 

36

 

 

 

90

 

 

 

36

 

Series A-1 convertible preferred stock

 

 

17

 

 

 

17

 

 

 

17

 

 

 

17